Chloe Kim
Private-Equity-Analyst bei Hanwha Impact Partners, Inc.
Profil
Chloe Kim, Ph.D.
joined Bioluminescence Ventures as a Partner in 2022.
Dr. Kim is a biomedical engineer / cell biologist by training with scientific expertise across regenerative medicine, oncology, immunology, and neuroscience.
Prior to joining BLV, she worked in business development and corporate strategy at a major Korean biopharmaceutical company.
Prior to that, she worked as a life science strategy consultant at Charles River Associates in San Francisco, where she specialized in commercial strategy projects for oncology and immunology therapeutics.
Dr. Kim holds both a Ph.D.
and an M.S.
in Biomedical Engineering from the University of Wisconsin-Madison, and a B.S.
in Bioengineering and Biomedical Engineering from UC Berkeley.
Aktive Positionen von Chloe Kim
Unternehmen | Position | Beginn |
---|---|---|
Hanwha Impact Partners, Inc.
Hanwha Impact Partners, Inc. Investment ManagersFinance Hanwha Impact Partners Inc (Hanwha Impact Partners) is a venture capital firm founded in 2022 by Kouki Harasaki. The firm is headquartered in San Francisco, California. | Private-Equity-Analyst | 01.06.2022 |
Ausbildung von Chloe Kim
University of California | Undergraduate Degree |
University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Hanwha Impact Partners, Inc.
Hanwha Impact Partners, Inc. Investment ManagersFinance Hanwha Impact Partners Inc (Hanwha Impact Partners) is a venture capital firm founded in 2022 by Kouki Harasaki. The firm is headquartered in San Francisco, California. | Finance |